Funded Projects

Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.

Reset
Project # Project Title Research Focus Area Research Program Administering IC Institution(s) Investigator(s) Location(s) Year Awarded
1R01AA031890-01
Advancing Integrated Treatment for Co-Occurring Opioid and Alcohol Use Disorders: A Comprehensive Analysis of GLP-1 Receptor Agonists and Traditional Pharmacotherapies in Real-World Settings Translation of Research to Practice for the Treatment of Opioid Addiction NIAAA LOYOLA UNIVERSITY CHICAGO QEADAN, FARES Maywood, IL 2024
NOFO Title: HEAL Initiative: Developing an Evidence Base for Co-Occurring OUD-AUD Interventions (R01 Clinical Trial Optional)
NOFO Number: RFA-AA-23-005
4R44DA053845-02
Fast-track: Scalable digital delivery of evidence-based training for addiction professionals to maximize treatment admission and retention rates of opioid use disorder in affected families Cross-Cutting Research Small Business Programs NIDA WE THE VILLAGE, INC. MACKY, JANE Brooklyn, NY 2024
NOFO Title: HEAL Initiative: Americas Startups and Small Businesses Build Technologies to Stop the Opioid Epidemic (R43/R44 - Clinical Trial Optional)
NOFO Number: RFA-DA-19-019
4R33DA057667-02
CADENCE - Continuous And Data-drivEN CarE Cross-Cutting Research Translating Data 2 Action to Prevent Overdose NIDA UNIVERSITY OF SOUTH FLORIDA MARSHALL, JENNIFER (contact); WRIGHT, TANNER Tampa, FL 2024
NOFO Title: HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-22-051
1R61DA061365-01
An innovative, trauma-informed approach for reducing overdose risk among women re-entering the community from prison Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA UNIVERSITY OF KENTUCKY STATON, MICHELE (contact); KNIGHT, KEVIN Lexington, KY 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053
1R61DA062357-01
Strength in HEALing: Indigenous Community-Led Strategies to Treat Stimulant Use Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA WASHINGTON STATE UNIVERSITY HIRCHAK, KATHERINE Pullman, WA 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053
1R61DA061723-01
Coalition for harm reduction and prevention (CHRP): Developing and testing a novel Hub and Spoke Model to implement prevention and harm reduction in rural clinics New Strategies to Prevent and Treat Opioid Addiction NIDA UNIVERSITY OF MICHIGAN LIN, LEWEI ALLISON Ann Arbor, MI 2024
NOFO Title: Rural Community-Centered Drug Misuse Prevention and Harm Reduction Research: Addressing Implementation, Dissemination, and Equity Challenges across the Continuum of Care (R61/R33 Clinical Trial Only)
NOFO Number: RFA-DA-24-036
2UM1DA050098-02
Methodology and Advanced Analytics Resource Center 2.0 Translation of Research to Practice for the Treatment of Opioid Addiction Justice Community Opioid Innovation Network (JCOIN) NIDA UNIVERSITY OF CHICAGO SCHNEIDER, JOHN (contact); BREWER, RUSSELL; POLLACK, HAROLD ALEXANDER Chicago, IL 2024
NOFO Title: HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed)
NOFO Number: RFA-DA-24-068
2UG1HD104251-02
UAB Outcomes of Babies with Opioid Exposure (OBOE study) Enhanced Outcomes for Infants and Children Exposed to Opioids Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) NICHD UNIVERSITY OF ALABAMA AT BIRMINGHAM AMBALAVANAN, NAMASIVAYAM (contact); PERALTA-CARCELEN, ADA MYRIAM Birmingham, AL 2024
NOFO Title: HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed)
NOFO Number: RFA-HD-24-014
4UF1MH121944-02
The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions New Strategies to Prevent and Treat Opioid Addiction Optimizing Care for People with Opioid Use Disorder and Mental Health Conditions NIMH UNIVERSITY OF PENNSYLVANIA MANDELL, DAVID S (contact); BOGNER, HILLARY R; KAMPMAN, KYLE MATTHEW Philadelphia, PA 2024
NOFO Title: HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial)
NOFO Number: RFA-MH-19-525
1OT2DA060972-01
Yakama Nation: Native Collective Research Effort to Enhance Wellness Program Translation of Research to Practice for the Treatment of Opioid Addiction Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain NIDA CONFEDERATED TRIBES AND BANDS OF THE YAKAMA NATION SALUSKIN, KATHERINE R (contact); GEORGE, NACHYA Toppenish, WA 2024
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007
1OT2DA061143-01
Indigenous Strengths as Solutions in a Public Health Crisis (Project ISH) Translation of Research to Practice for the Treatment of Opioid Addiction Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain NIDA NORTHWEST INDIAN COLLEGE ALEXANDER, CHARENE (contact); JUAREZ, BARBARA A Bellingham, WA 2024
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007
1OT2DA061113-01
Absentee Shawnee Tribal Health System: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program- Addressing Overdose, Substance Use, Mental Health, and Pain (OT2) Translation of Research to Practice for the Treatment of Opioid Addiction Native Collective Research Effort to Enhance Wellness (N CREW) Program: Addressing Overdose, Substance Use, Mental Health, and Pain NIDA ABSENTEE SHAWNEE TRIBE OF OKLAHOMA PATERNITE, HADYN KERNAL (contact); NAEL, SIAVASH Shawnee, OK 2024
NOFO Title: HEAL Initiative: Native Collective Research Effort to Enhance Wellness (N CREW) Program - Addressing Overdose, Substance Use, Mental Health, and Pain (OT2)
NOFO Number: OTA-23-007
1R21DA060304-01A1
Semaglutide for the treatment of opioid use disorder: A pilot randomized controlled trial Novel Therapeutic Options for Opioid Use Disorder and Overdose NIDA BRIGHAM AND WOMEN'S HOSPITAL SUZUKI, JOJI Boston, MA 2024
NOFO Title: NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
NOFO Number: PA-20-194
3R01DA057605-01S3
Enhancing opioid surveillance in RADOR-KY using social media Cross-Cutting Research Leveraging Existing and Real-Time Opioid and Pain Management Data NIDA UNIVERSITY OF KENTUCKY SLAVOVA, SVETLA STEFANOVA (contact); TALBERT, JEFFERY C Lexington, KY 2024
NOFO Title: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NOFO Number: PA-20-272
1R43DA058603-01A1
Developing a novel epigenetic regulator as a treatment for opioid use disorder Cross-Cutting Research Small Business Programs NIDA EPIVARIO, LLC KIM, THOMAS Philadelphia, PA 2024
NOFO Title: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
NOFO Number: PA-22-176
3U01DA055355-04S1
9/24- Healthy Brain and Child Development National Consortium Training the Next Generation of Researchers in HEAL NIDA NORTHWESTERN UNIVERSITY CHICAGO WAKSCHLAG, LAUREN S (contact); NORTON, ELIZABETH SPENCER Chicago, IL 2024
NOFO Title: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
NOFO Number: PA-23-189
4UH3DA054825-03
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder. Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA ASTRAZENECA PHARMACEUTICALS, LP GURRELL, IAN Wilmington, DE 2024
NOFO Title: Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional)
NOFO Number: PAR-20-092
1U01DA059994-01
Efficacy, safety, and pharmacokinetic study of BICX104 naltrexone subcutaneous implant alone and in combination with bupropion for the treatment of Methamphetamine Use Disorder (MUD). Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose NIDA BIOCORRX PHARMACEUTICALS, INC. DEVARNEY, KATE BEEBE Anaheim, CA 2024
NOFO Title: Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
NOFO Number: PAR-22-202
1K01DA061078-01
Reducing opioid misuse among urban Indigenous young adults in Montana using a culturally centered intervention Training the Next Generation of Researchers in HEAL NIDA UNIVERSITY OF MONTANA CHASE-BEGAY, DAMIAN M Missoula, MT 2024
NOFO Title: HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
NOFO Number: PAS-22-206
3R01AI145910-06S1
Dysregulation of maternal immunity during pregnancy by pregravid obesity Enhanced Outcomes for Infants and Children Exposed to Opioids NIAID UNIVERSITY OF KENTUCKY MESSAOUDI, ILHEM Lexington, KY 2024
NOFO Title: Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)
NOFO Number: RFA-AI-18-023
4R24DA051975-02
Innovations in Recovery through Infrastructure Support (IRIS) Translation of Research to Practice for the Treatment of Opioid Addiction Recovery Research Networks NIDA UNIVERSITY OF MARYLAND BALTIMORE UNICK, GEORGE J (contact); TUTEN, LUCILLE MICHELLE Baltimore, MD 2024
NOFO Title: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional)
NOFO Number: RFA-DA-20-014
4R44DA058467-02
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder Cross-Cutting Research Small Business Programs NIDA VIVREON BIOSCIENCES, LLC GREENBERG, MILTON L San Diego, CA 2024
NOFO Title: Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
NOFO Number: RFA-DA-23-021
1R61DA061340-01A1
PATH to reducing burnout among peers who deliver harm reduction services: Improving workforce and service system outcomes through a combined eLearning and group consultation intervention Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA CHESTNUT HEALTH SYSTEMS, INC. WATSON, DENNIS PAUL Bloomington, IL 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-053
1R33DA062346-01
Reversing Overdose Epidemics through Simulation, Collaboration, and Unified Efforts (RESCUE) Translation of Research to Practice for the Treatment of Opioid Addiction Optimizing the Quality, Reach, and Impact of Addiction Services NIDA UNIVERSITY OF MINNESOTA ZANG, XIAO (contact); MARSHALL, BRANDON DAVID LEWIS Minneapolis, MN 2024
NOFO Title: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
NOFO Number: RFA-DA-23-054
1R21DA062182-01
The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System Cross-Cutting Research NIDA RAND CORPORATION KALMIN, MARIAH Santa Monica, CA 2024
NOFO Title: Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
NOFO Number: RFA-DA-24-037